2021/3/7  
英文 English 
CECC defends safety profile of AstraZeneca vaccine (2021/02/23)

Taiwan reported no new COVID cases on Tuesday for the third day in a row. The Central Epidemic Command Center announced that test results had come back negative for the 36 Taiwanese recently evacuated from Myanmar. CECC officials also defended the safety profile of AstraZeneca vaccines, which will soon roll out in Taiwan. Citing data from the World Health Organization, they said side effects were in fact less common for AstraZeneca vaccines than those by other manufacturers.

AstraZeneca vaccines will soon arrive in Taiwan. It's been reported that in France and Sweden, the use of this vaccine has been restricted for health care workers amid concerns over side effects. The CECC said Tuesday that compared to other vaccines, the AstraZeneca jab is in fact less likely to induce side effects.

Lo Yi-chun
Central Epidemic Command Center
If there are any side effects, they'll manifest on the first shot. After the second jab, they are generally much milder, or they don't develop at all. The BioNTech-Pfizer and the Moderna vaccines are mRNA vaccines. That means that these vaccines are more likely to show side effects after the second dose instead of the first.

Let's compare how common side effects were for AstraZeneca, BioNTech and Moderna vaccines in clinical trials. The AstraZeneca vaccine was less likely to leave tenderness at the injection site. Side effects such as tiredness and headaches were also less common, as was developing a fever.

Health minister Chen Shih-chung said that administering the second dose eight weeks after the first confers greater higher protection.

Chen Shih-chung
Central Epidemic Command Center
The AstraZeneca vaccine offers 76% protection after the first jab. Postponing the second jab to more than 12 weeks after the first one pushes its effectiveness up to 82.4%.

In a poll conducted by the CECC, 66.1% of respondents said they were willing to get vaccinated, versus 27.9% who said they were not.

Chen Shih-chung
Central Epidemic Command Center
We can't force everyone to get the vaccine, but we can make the process transparent. I believe that with more transparent information comes a greater level of trust. First, we need to lower the high number of infections. Once there are fewer confirmed cases, life can return to normal. Once that is accomplished, people can start thinking about international travel.

Chen named the three steps of the global vaccination action plan. For Taiwan, restoring normal international travel is the only step that remains. Chen emphasized that the government would work to design the optimal vaccination plan, be it using imported or domestically produced vaccines.
中文 Chinese  
連續3天+0 ! 陳時中:AZ疫苗2劑隔8週打更有效

連續三天本土、境外都+0,緬甸返台的36位僑民篩檢也陰性。對即將抵台的AZ疫苗副作用傳聞不斷,指揮中心今天澄清,瑞典、法國並沒有停打,還公布WHO三大疫苗副作用報告,AZ並沒有比較多。陳時中還說,2劑接種間隔8周效力更高。

AZ疫苗就要來台,但傳出法國、瑞典因為接種後副作用,醫護暫緩施打,指揮中心澄清,並強調AZ疫苗副作用其實相對少。

[[指揮中心醫療應變組副組長 羅一鈞]]
"如果有副作用的話,打第一劑就會出現。打第二劑的時候,事實上症狀通常會輕微很多,甚至就是沒有副作用。BNT輝瑞或是Moderna,他們屬於mRNA疫苗,這類的疫苗它們產生副作用的機率,就是變成打第二劑的時候,比較容易會發生。"

整理AZ、BNT和Moderna三期臨床試驗的副作用發生比例,注射部位疼痛度,就以AZ勝出,疲倦和頭痛也是AZ副作用小。發燒比例部分,AZ也沒輸給其他另外兩支疫苗。

陳時中甚至說,2劑接種間隔8周效力更高。

[[疫情指揮中心指揮官 陳時中]]
"AZ疫苗接種第一劑,接種一劑的效力為76%,延長第二劑接種時間點為12周以上,疫苗效力可以提升為82.4%。"

根據指揮中心的民調,願意接種疫苗達66.1%,不願接種達27.9%,顯然不少人仍有疑慮。

[[疫情指揮中心指揮官 陳時中]]
"也沒有辦法去強迫大家一定要打,就讓它能夠透明啦,我相信資訊越透明,大家信心就會越好,開始希望說確診高的能夠往下降,確診降下來之後,希望能夠恢復正常生活,這些都達到以後,開始大家會考慮國際之間的流通。"

陳時中訂出防疫三階段目標,現在就剩下恢復國際流通未達成。不管國產研發或進口採購研發,指揮中心保證會訂出最好疫苗施打策略。
關於民視 常見問題 如何收看民視 意見信箱

© 2009 FTV All Rights Reserved 版權所有‧盜用必究 Designed by FTV
地址:244 新北市林口區信義路99號   觀服電話:(02)8601-8601 服務時間:週一至週日09:00-21:00   傳真:(02)8601-3955

本網站使用 cookie 與其他技術為您提供更好的使用體驗, 請閱讀我們的的隱私權政策,通過使用我們的網站,表示您確認並同意我們的政策。